184 related articles for article (PubMed ID: 36472914)
1. Interfering with lipid metabolism through targeting CES1 sensitizes hepatocellular carcinoma for chemotherapy.
Li G; Li X; Mahmud I; Ysaguirre J; Fekry B; Wang S; Wei B; Eckel-Mahan KL; Lorenzi PL; Lehner R; Sun K
JCI Insight; 2023 Jan; 8(2):. PubMed ID: 36472914
[TBL] [Abstract][Full Text] [Related]
2. Potential Regulatory Role of Human-Carboxylesterase-1 Glycosylation in Liver Cancer Cell Growth.
Na K; Kim M; Kim CY; Lim JS; Cho JY; Shin H; Lee HJ; Kang BJ; Han DH; Kim H; Baik JH; Swiatek-de Lange M; Karl J; Paik YK
J Proteome Res; 2020 Dec; 19(12):4867-4883. PubMed ID: 33206527
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in human carboxylesterase CES1 confers resistance to hepatic steatosis.
Lian J; Bahitham W; Panigrahi R; Nelson R; Li L; Watts R; Thiesen A; Lemieux MJ; Lehner R
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jul; 1863(7):688-699. PubMed ID: 29631096
[TBL] [Abstract][Full Text] [Related]
4. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
[TBL] [Abstract][Full Text] [Related]
5. CES1 Releases Oxylipins from Oxidized Triacylglycerol (oxTAG) and Regulates Macrophage oxTAG/TAG Accumulation and PGE
Phillips ME; Adekanye O; Borazjani A; Crow JA; Ross MK
ACS Chem Biol; 2023 Jul; 18(7):1564-1581. PubMed ID: 37348046
[TBL] [Abstract][Full Text] [Related]
6. Activity-based protein profiling identifies a host enzyme, carboxylesterase 1, which is differentially active during hepatitis C virus replication.
Blais DR; Lyn RK; Joyce MA; Rouleau Y; Steenbergen R; Barsby N; Zhu LF; Pegoraro AF; Stolow A; Tyrrell DL; Pezacki JP
J Biol Chem; 2010 Aug; 285(33):25602-12. PubMed ID: 20530478
[TBL] [Abstract][Full Text] [Related]
7. Yin Yang 1 facilitates hepatocellular carcinoma cell lipid metabolism and tumor progression by inhibiting PGC-1β-induced fatty acid oxidation.
Li Y; Kasim V; Yan X; Li L; Meliala ITS; Huang C; Li Z; Lei K; Song G; Zheng X; Wu S
Theranostics; 2019; 9(25):7599-7615. PubMed ID: 31695789
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2.
Xie S; Borazjani A; Hatfield MJ; Edwards CC; Potter PM; Ross MK
Chem Res Toxicol; 2010 Dec; 23(12):1890-904. PubMed ID: 21049984
[TBL] [Abstract][Full Text] [Related]
9. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
[TBL] [Abstract][Full Text] [Related]
10. Sortilin 1 Modulates Hepatic Cholesterol Lipotoxicity in Mice via Functional Interaction with Liver Carboxylesterase 1.
Li J; Wang Y; Matye DJ; Chavan H; Krishnamurthy P; Li F; Li T
J Biol Chem; 2017 Jan; 292(1):146-160. PubMed ID: 27881673
[TBL] [Abstract][Full Text] [Related]
11. Targeting ODC1 inhibits tumor growth through reduction of lipid metabolism in human hepatocellular carcinoma.
Choi Y; Oh ST; Won MA; Choi KM; Ko MJ; Seo D; Jeon TW; Baik IH; Ye SK; Park KU; Park IC; Jang BC; Seo JY; Lee YH
Biochem Biophys Res Commun; 2016 Sep; 478(4):1674-81. PubMed ID: 27592554
[TBL] [Abstract][Full Text] [Related]
12. Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1.
Wu D; Yang Y; Hou Y; Zhao Z; Liang N; Yuan P; Yang T; Xing J; Li J
Cancer Commun (Lond); 2022 Jan; 42(1):37-55. PubMed ID: 34981667
[TBL] [Abstract][Full Text] [Related]
13. Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function.
Zhang J; Zhang W; Yang L; Zhao W; Liu Z; Wang E; Wang J
Phytomedicine; 2023 Jan; 109():154589. PubMed ID: 36610145
[TBL] [Abstract][Full Text] [Related]
14. β-catenin-activated hepatocellular carcinomas are addicted to fatty acids.
Senni N; Savall M; Cabrerizo Granados D; Alves-Guerra MC; Sartor C; Lagoutte I; Gougelet A; Terris B; Gilgenkrantz H; Perret C; Colnot S; Bossard P
Gut; 2019 Feb; 68(2):322-334. PubMed ID: 29650531
[TBL] [Abstract][Full Text] [Related]
15. Carboxylesterase1/Esterase-x regulates chylomicron production in mice.
Quiroga AD; Lian J; Lehner R
PLoS One; 2012; 7(11):e49515. PubMed ID: 23145182
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance and functional role of transmembrane protein 47 (TMEM47) in chemoresistance of hepatocellular carcinoma.
Ng KT; Yeung OW; Liu J; Li CX; Liu H; Liu XB; Qi X; Ma YY; Lam YF; Lau MY; Qiu WQ; Shiu HC; Lai MK; Lo CM; Man K
Int J Oncol; 2020 Oct; 57(4):956-966. PubMed ID: 32945373
[TBL] [Abstract][Full Text] [Related]
17. Identification of palmitoyl protein thioesterase 1 in human THP1 monocytes and macrophages and characterization of unique biochemical activities for this enzyme.
Wang R; Borazjani A; Matthews AT; Mangum LC; Edelmann MJ; Ross MK
Biochemistry; 2013 Oct; 52(43):7559-74. PubMed ID: 24083319
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel intracellular cholesteryl ester hydrolase (carboxylesterase 3) in human macrophages: compensatory increase in its expression after carboxylesterase 1 silencing.
Zhao B; Bie J; Wang J; Marqueen SA; Ghosh S
Am J Physiol Cell Physiol; 2012 Aug; 303(4):C427-35. PubMed ID: 22700792
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma.
Liu Z; Wang Y; Dou C; Sun L; Li Q; Wang L; Xu Q; Yang W; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Mar; 37(1):49. PubMed ID: 29510736
[TBL] [Abstract][Full Text] [Related]
20. Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling.
Ma APY; Yeung CLS; Tey SK; Mao X; Wong SWK; Ng TH; Ko FCF; Kwong EML; Tang AHN; Ng IO; Cai SH; Yun JP; Yam JWP
Cancer Res; 2021 Jul; 81(13):3679-3692. PubMed ID: 33975883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
